Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Homology Medicines IncFIXX-10.832,006.0619.460.30-90.02%-471.17%52.74$39.70$45.229,141$24.55

Detail of Homology Medicines Inc

 
Employees
224
Industry
Biotechnology
Sector
Healthcare
Market cap
$1B

Company details

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, cardiac and skeletal muscle, and eye. Its lead product candidate is HMI-102, which is in Phase 2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II, as well as HMI-104 for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.

Revenue
Revenue (Rev)
$708,000.00
Homology Medicines Inc
FIXX • XNGS • US
$24.55
+23.98 (4,242.06%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$2.27
Margin profit
0.00%
52 week low
$0.5776
52 week high
$51.875
50-day simple moving average
$35.07
200-day simple moving average
$39.70
Percent held by insiders
9.29%
Percent held by institutions
46.76%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
FIXX +4,166.60%
eps change
FIXX 0.00%